The forecast for hospital discharges for hyperplasia of the prostate in Canada shows a gradual decline, with values decreasing from 69.1 per hundred thousand persons in 2024 to 66.7 in 2028. This indicates a steady year-on-year decrease between 1% and 1.5%. In 2023, the figure stood slightly above 69.1, suggesting a continuing downward trend. The Compound Annual Growth Rate (CAGR) implies an average reduction of approximately 0.9% per year over the five-year forecast period.
Future trends to watch for include advancements in medical treatments and early diagnostic methods, which could potentially accelerate the decline in hospital discharges. Additionally, public health initiatives aimed at improving men’s health awareness may further influence these numbers downward over the coming years.
